Mechanisms of cardiac fibrosis in inflammatory heart disease

Trends in Cardiovascular Medicine

Volumn 19, Issue 8, 2009, Pages 247-252

  Kania, Gabriela ^a   Blyszczuk, Przemyslaw ^a   Eriksson, Urs ^a,b  

^a UNIVERSITY OF ZURICH   (Switzerland)

^b UNIVERSITY HOSPITAL ZURICH   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOTENSIN 1 RECEPTOR ANTAGONIST; COLLAGEN; CYTOKINE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; TRANSFORMING GROWTH FACTOR BETA; TUMOR NECROSIS FACTOR ALPHA INHIBITOR; VITAMIN D DERIVATIVE;

ANGIOGENESIS; CELL DIFFERENTIATION; CELL INFILTRATION; CLINICAL TRIAL; CONGESTIVE CARDIOMYOPATHY; DISEASE COURSE; HEART FAILURE; HEART INJURY; HEART MUSCLE FIBROSIS; HEART MUSCLE INJURY; HEART VENTRICLE REMODELING; HUMAN; MONOCYTE; MYOCARDITIS; NONHUMAN; PATHOGENESIS; PHENOTYPE; PRIORITY JOURNAL; REVIEW; STEM CELL;

ADAPTATION, PHYSIOLOGICAL; ANIMALS; CARDIOMYOPATHY, DILATED; CELL MOVEMENT; CYTOKINES; DISEASE PROGRESSION; EPIGENESIS, GENETIC; FIBROSIS; HEART FAILURE; HUMANS; INFLAMMATION MEDIATORS; MONOCYTES; MYOCARDITIS; MYOCARDIUM; STEM CELLS; VENTRICULAR REMODELING;

EID: 77952501955     PISSN: 10501738     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.tcm.2010.02.005     Document Type: Review

References (46)

1. Afanasyeva M., Georgakopoulos D., Rose N.R. Autoimmune myocarditis: cellular mediators of cardiac dysfunction. Autoimmun Rev 2004, 3:476-486.
2. Anversa P., Kajstura J., Leri A., et al. Life and death of cardiac stem cells: a paradigm shift in cardiac biology. Circulation 2006, 113:1451-1463.
3. Aretz H.T., Billingham M.E., Edwards W.D., et al. Myocarditis. A histopathologic definition and classification. Am J Cardiovasc Pathol 1987, 1:3-14.
4. Balsam L.B., Wagers A.J., Christensen J.L., et al. Haematopoietic stem cells adopt mature haematopoietic fates in ischaemic myocardium. Nature 2004, 428:668-673.
5. Bartunek J., Croissant J.D., Wijns W., et al. Pretreatment of adult bone marrow mesenchymal stem cells with cardiomyogenic growth factors and repair of the chronically infarcted myocardium. Am J Physiol Heart Circ Physiol 2007, 292:H1095-H1104.
6. Blyszczuk P., Kania G., Dieterle T., et al. Myeloid differentiation factor-88/interleukin-1 signaling controls cardiac fibrosis and heart failure progression in inflammatory dilated cardiomyopathy. Circ Res 2009, 105:912-920.
7. Blyszczuk P., Valaperti A., Eriksson U. Future therapeutic strategies in inflammatory cardiomyopathy: insights from the experimental autoimmune myocarditis model. Cardiovasc Hematol Disord Drug Targets 2008, 8:313-321.
8. Bujak M., Dobaczewski M., Chatila K., et al. Interleukin-1 receptor type I signaling critically regulates infarct healing and cardiac remodeling. Am J Pathol 2008, 173:57-67.
9. Bujak M., Frangogiannis N.G. The role of TGF-beta signaling in myocardial infarction and cardiac remodeling. Cardiovasc Res 2007, 74:184-195.
10. Bujak M., Ren G., Kweon H.J., et al. Essential role of Smad3 in infarct healing and in the pathogenesis of cardiac remodeling. Circulation 2007, 116:2127-2138.
11. Cucoranu I., Clempus R., Dikalova A., et al. NAD(P)H oxidase 4 mediates transforming growth factor-beta1-induced differentiation of cardiac fibroblasts into myofibroblasts. Circ Res 2005, 97:900-907.
12. D'Armiento J. Matrix metalloproteinase disruption of the extracellular matrix and cardiac dysfunction. Trends Cardiovasc Med 2002, 12:97-101.
13. El-Helou V., Dupuis J., Proulx C., et al. Resident nestin+ neural-like cells and fibers are detected in normal and damaged rat myocardium. Hypertension 2005, 46:1219-1225.
14. Endo J., Sano M., Fujita J., et al. Bone marrow derived cells are involved in the pathogenesis of cardiac hypertrophy in response to pressure overload. Circulation 2007, 116:1176-1184.
15. Fairweather D., Yusung S., Frisancho S., et al. IL-12 receptor beta 1 and Toll-like receptor 4 increase IL-1 beta- and IL-18-associated myocarditis and coxsackievirus replication. J Immunol 2003, 170:4731-4737.
16. Francis G.S. TNF-alpha and heart failure. The difference between proof of principle and hypothesis testing. Circulation 1999, 99:3213-3214.
17. Fujita J., Mori M., Kawada H., et al. Administration of granulocyte colony-stimulating factor after myocardial infarction enhances the recruitment of hematopoietic stem cell-derived myofibroblasts and contributes to cardiac repair. Stem Cells 2007, 25:2750-2759.
18. Gnecchi M., Zhang Z., Ni A., et al. Paracrine mechanisms in adult stem cell signaling and therapy. Circ Res 2008, 103:1204-1219.
19. Godsel L.M., Leon J.S., Engman D.M. Angiotensin converting enzyme inhibitors and angiotensin II receptor antagonists in experimental myocarditis. Curr Pharm Des 2003, 9:723-735.
20. Goser S., Andrassy M., Buss S.J., et al. Cardiac troponin I but not cardiac troponin T induces severe autoimmune inflammation in the myocardium. Circulation 2006, 114:1693-1702.
21. Hara M., Ono K., Hwang M.W., et al. Evidence for a role of mast cells in the evolution to congestive heart failure. J Exp Med 2002, 195:375-381.
22. Haudek S.B., Xia Y., Huebener P., et al. Bone marrow-derived fibroblast precursors mediate ischemic cardiomyopathy in mice. Proc Natl Acad Sci U S A 2006, 103:18284-18289.
23. Higuchi H., Hara M., Yamamoto K., et al. Mast cells play a critical role in the pathogenesis of viral myocarditis. Circulation 2008, 118:363-372.
24. Kallwellis-Opara A., Dorner A., Poller W.C., et al. Autoimmunological features in inflammatory cardiomyopathy. Clin Res Cardiol 2007, 96:469-480.
25. Kania G., Blyszczuk P., Stein S., et al. Heart-infiltrating prominin-1+/CD133+ progenitor cells represent the cellular source of transforming growth factor beta-mediated cardiac fibrosis in experimental autoimmune myocarditis. Circ Res 2009, 105:462-470.
26. Kania G., Blyszczuk P., Valaperti A., et al. Prominin-1+/CD133+ bone marrow-derived heart-resident cells suppress experimental autoimmune myocarditis. Cardiovasc Res 2008, 80:236-245.
27. Kubota T., McTiernan C.F., Frye C.S., et al. Dilated cardiomyopathy in transgenic mice with cardiac-specific overexpression of tumor necrosis factor-alpha. Circ Res 1997, 81:627-635.
28. Kwon H.J., Cote T.R., Cuffe M.S., et al. Case reports of heart failure after therapy with a tumor necrosis factor antagonist. Ann Intern Med 2003, 138:807-811.
29. Lang C., Sauter M., Szalay G., et al. Connective tissue growth factor: a crucial cytokine-mediating cardiac fibrosis in ongoing enterovirus myocarditis. J Mol Med 2008, 86:49-60.
30. Leipner C., Grun K., Muller A., et al. Imatinib mesylate attenuates fibrosis in coxsackievirus b3-induced chronic myocarditis. Cardiovasc Res 2008, 79:118-126.
31. Manabe I., Shindo T., Nagai R. Gene expression in fibroblasts and fibrosis: involvement in cardiac hypertrophy. Circ Res 2002, 91:1103-1113.
32. McCarthy R.E., Boehmer J.P., Hruban R.H., et al. Long-term outcome of fulminant myocarditis as compared with acute (nonfulminant) myocarditis. N Engl J Med 2000, 342:690-695.
33. Mollmann H., Nef H.M., Kostin S., et al. Bone marrow-derived cells contribute to infarct remodelling. Cardiovasc Res 2006, 71:661-671.
34. Murry C.E., Soonpaa M.H., Reinecke H., et al. Haematopoietic stem cells do not transdifferentiate into cardiac myocytes in myocardial infarcts. Nature 2004, 428:664-668.
35. Nahrendorf M., Swirski F.K., Aikawa E., et al. The healing myocardium sequentially mobilizes two monocyte subsets with divergent and complementary functions. J Exp Med 2007, 204:3037-3047.
36. Nygren J.M., Liuba K., Breitbach M., et al. Myeloid and lymphoid contribution to non-haematopoietic lineages through irradiation-induced heterotypic cell fusion. Nat Cell Biol 2008, 10:584-592.
37. Okada H., Suzuki J., Futamatsu H., et al. Attenuation of autoimmune myocarditis in rats by mesenchymal stem cell transplantation through enhanced expression of hepatocyte growth factor. Int Heart J 2007, 48:649-661.
38. Phan S.H. The myofibroblast in pulmonary fibrosis. Chest 2002, 122:286S-289S.
39. Pohlers D., Brenmoehl J., Loffler I., et al. TGF-beta and fibrosis in different organs: molecular pathway imprints. Biochim Biophys Acta 2009, 1792:746-756.
40. Porter K.E., Turner N.A. Cardiac fibroblasts: at the heart of myocardial remodeling. Pharmacol Ther 2009, 123:255-278.
41. Segers V.F., Lee R.T. Stem-cell therapy for cardiac disease. Nature 2008, 451:937-942.
42. Szalay G., Sauter M., Haberland M., et al. Osteopontin: a fibrosis-related marker molecule in cardiac remodeling of enterovirus myocarditis in the susceptible host. Circ Res 2009, 104:851-859.
43. Valaperti A., Marty R.R., Kania G., et al. CD11b+ monocytes abrogate Th17 CD4+ T cell-mediated experimental autoimmune myocarditis. J Immunol 2008, 180:2686-2695.
44. van Amerongen M.J., Bou-Gharios G., Popa E., et al. Bone marrow-derived myofibroblasts contribute functionally to scar formation after myocardial infarction. J Pathol 2008, 214:377-386.
45. Yano T., Miura T., Ikeda Y., et al. Intracardiac fibroblasts, but not bone marrow derived cells, are the origin of myofibroblasts in myocardial infarct repair. Cardiovasc Pathol 2005, 14:241-246.
46. Zeisberg E.M., Tarnavski O., Zeisberg M., et al. Endothelial-to-mesenchymal transition contributes to cardiac fibrosis. Nat Med 2007, 13:952-961.